Status
Conditions
Treatments
About
The randomized, open-label, two period crossover single-dose bioavailability study with two coenzyme Q10 products
Full description
The randomized, open-label, two period crossover single-dose bioavailability study with two coenzyme Q10 products will include 35 subjects who will test two different coenzyme Q10 products. Plasma concentration of coenzyme Q10 will be measured.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
25 participants in 2 patient groups
Loading...
Central trial contact
Zala Jenko Pražnikar, phD; Ana Petelin, phD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal